Desmin-related cardiomyopathy therapeutics development

Innovative therapeutics targeting genetic-driven dilated cardiomyopathy (DCM) using human induced pluripotent stem cells (hiPSC) and engineered heart tissue models. Aims to identify drug candidates that address cellular ...